Recombinant Human CD84/SLAMF5 Protein
Beta LifeScience
SKU/CAT #: BLK-02433P-100UG
Human CD84 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CD84/SLAMF5 Protein
Beta LifeScience
SKU/CAT #: BLK-02433P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CD84/SLAMF5 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Lys22-Gly225. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9UIB8 |
Target Symbol | CD84/SLAMF5 |
Synonyms | Hly9-beta; CD84; SLAMF5; LY9B; CD84 molecule; DKFZp781E2378 |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Lys22-Gly225 |
Mol. Weight | The protein has a predicted MW of 25.4 kDa. Due to glycosylation, the protein migrates to 40-55 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5 B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells due to decreased apoptosis. CD84 belongs to the signaling lymphocyte activating molecule family of immunoreceptors, and has an unknown function in CLL cells. |